Harvard Bioscience, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $9.3M | $8.2M | $1.2M | $3.6M |
| FY2021 | $1.3M | $67.0K | $1.2M | $4.2M |
| FY2022 | $1.2M | $-438.0K | $1.6M | $4.4M |
| FY2023 | $14.0M | $12.2M | $1.8M | $5.0M |
| FY2024 | $1.4M | $-1.2M | $2.6M | $4.3M |